Breaking News, Collaborations & Alliances

Rentschler Extends Collaboration with Genmab to U.S. Facility

Agreement provides flexible model to address Genmab’s development and manufacturing needs as programs advance in development

By: Contract Pharma

Contract Pharma Staff

Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has entered into a collaboration with Genmab for the process development and manufacture of bispecific antibodies generated with Genmab’s DuoBody technology platform. This partnership uses an innovative business model which fits well with the expansion plans for Rentschler Biopharma’s U.S. site in Milford, MA.   “We are excited to expand our strategic partnership with Genmab, a ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters